Cannabinoid receptors CB1 and CB2 form functional heteromers in the brain

Exploring the role of cannabinoid CB2 receptors in the brain, we present evidence of CB2 receptor molecular and functional interaction with cannabinoid CB1 receptors. Using biophysical and biochemical approaches, we discovered that CB2 receptors can form heteromers with CB1 receptors in transfected...

ver descrição completa

Detalhes bibliográficos
Autores: Callén Herrero, Lucía, Moreno Guillén, Estefanía, Barroso-Chinea, Pedro, Moreno-Delgado, David, Cortés Tejedor, Antonio, Mallol Montero, Josefa, Casadó, Vicent, Lanciego, José Luis, Franco Fernández, Rafael, Lluís i Biset, Carme, Canela Campos, Enric I. (Enric Isidre), 1949-, McCormick, Peter J.
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2012
País:España
Recursos:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/122584
Acesso em linha:https://hdl.handle.net/2445/122584
Access Level:acceso abierto
Palavra-chave:Receptors cel·lulars
Cervell
Proteïnes
Cell receptors
Brain
Proteins
Descrição
Resumo:Exploring the role of cannabinoid CB2 receptors in the brain, we present evidence of CB2 receptor molecular and functional interaction with cannabinoid CB1 receptors. Using biophysical and biochemical approaches, we discovered that CB2 receptors can form heteromers with CB1 receptors in transfected neuronal cells and in rat brain pineal gland, nucleus accumbens, and globus pallidus. Within CB1-CB2 receptor heteromers expressed in a neuronal cell model, agonist co-activation of CB1 and CB2 receptors resulted in a negative cross-talk in Akt phosphorylation and neurite outgrowth. Moreover, one specific characteristic of CB1-CB2 receptor heteromers consists of both the ability of CB1 receptor antagonists to block the effect of CB2 receptor agonists and, conversely, the ability of CB2 receptor antagonists to block the effect of CB1 receptor agonists, showing a bidirectional cross-antagonism phenomenon. Taken together, these data illuminate the mechanism by which CB2 receptors can negatively modulate CB1 receptor function.